These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21145955)

  • 1. Method of modelling the compaction behaviour of cylindrical pharmaceutical tablets.
    Ahmat N; Ugail H; Castro GG
    Int J Pharm; 2011 Feb; 405(1-2):113-21. PubMed ID: 21145955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A material-sparing method for simultaneous determination of true density and powder compaction properties--aspartame as an example.
    Sun CC
    Int J Pharm; 2006 Dec; 326(1-2):94-9. PubMed ID: 16926076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The difficulty in the assessment of the compression behaviour of powder mixtures: Double layer tablets versus arithmetic additivity rule.
    Belda PM; Mielck JB
    Eur J Pharm Biopharm; 2005 May; 60(1):133-45. PubMed ID: 15848065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the distribution of density and tabletting force in pharmaceutical tablets by chemical imaging.
    Ellison CD; Ennis BJ; Hamad ML; Lyon RC
    J Pharm Biomed Anal; 2008 Sep; 48(1):1-7. PubMed ID: 18539424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of multivariate methods to compression behavior evaluation of directly compressible materials.
    Haware RV; Tho I; Bauer-Brandl A
    Eur J Pharm Biopharm; 2009 May; 72(1):148-55. PubMed ID: 19084596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A material-sparing method for assessment of powder deformation characteristics using data collected during a single compression-decompression cycle.
    Katz JM; Roopwani R; Buckner IS
    J Pharm Sci; 2013 Oct; 102(10):3687-93. PubMed ID: 23897398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling and simulation of compact strength due to particle bonding using a hybrid discrete-continuum approach.
    Koynov A; Akseli I; Cuitiño AM
    Int J Pharm; 2011 Oct; 418(2):273-85. PubMed ID: 21736930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow and compaction behaviour of ultrafine coated ibuprofen.
    More PK; Khomane KS; Bansal AK
    Int J Pharm; 2013 Jan; 441(1-2):527-34. PubMed ID: 23142495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential compaction behaviour of roller compacted granules of clopidogrel bisulphate polymorphs.
    Khomane KS; Bansal AK
    Int J Pharm; 2014 Sep; 472(1-2):288-95. PubMed ID: 24971694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry coating of micronized API powders for improved dissolution of directly compacted tablets with high drug loading.
    Han X; Ghoroi C; Davé R
    Int J Pharm; 2013 Feb; 442(1-2):74-85. PubMed ID: 22921376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative measurements of localized density variations in cylindrical tablets using X-ray microtomography.
    Busignies V; Leclerc B; Porion P; Evesque P; Couarraze G; Tchoreloff P
    Eur J Pharm Biopharm; 2006 Aug; 64(1):38-50. PubMed ID: 16621489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing compressibility and compactibility of powder formulations with Near-Infrared Spectroscopy.
    Gentis ND; Vranic BZ; Betz G
    Pharm Dev Technol; 2013 Feb; 18(1):156-71. PubMed ID: 22506493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of in-die powder densification parameters in the implementation of process analytical technologies for tablet production on industrial scale.
    Cespi M; Perinelli DR; Casettari L; Bonacucina G; Caporicci G; Rendina F; Palmieri GF
    Int J Pharm; 2014 Dec; 477(1-2):140-7. PubMed ID: 25304091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tableting Properties and Compression Models of Labisia pumila Tablets.
    Etti CJ; Yusof YA; Chin NL; Mohd Tahir S
    J Diet Suppl; 2017 Mar; 14(2):132-145. PubMed ID: 27487244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of temperature increase during the tableting of pharmaceutical materials.
    Cespi M; Bonacucina G; Casettari L; Ronchi S; Palmieri GF
    Int J Pharm; 2013 May; 448(1):320-6. PubMed ID: 23518365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An experimental evaluation of an effective medium based compaction equation.
    Mahmoodi F; Alderborn G; Frenning G
    Eur J Pharm Sci; 2012 May; 46(1-2):49-55. PubMed ID: 22366112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particle size distribution and evolution in tablet structure during and after compaction.
    Fichtner F; Rasmuson A; Alderborn G
    Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method for deriving true density of pharmaceutical solids including hydrates and water-containing powders.
    Sun CC
    J Pharm Sci; 2004 Mar; 93(3):646-53. PubMed ID: 14762903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding deformation mechanisms during powder compaction using principal component analysis of compression data.
    Roopwani R; Buckner IS
    Int J Pharm; 2011 Oct; 418(2):227-34. PubMed ID: 21624449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system.
    Aguilar-Díaz JE; García-Montoya E; Suñe-Negre JM; Pérez-Lozano P; Miñarro M; Ticó JR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):638-48. PubMed ID: 22245156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.